L&C Bio Co. Ltd
L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. The company offers pharmaceuticals, human tissue, medical device, and cosmetics products. L&C Bio Co., Ltd was founded in 2011 and is headquartered in Seongnam-si, South Korea.
L&C Bio Co. Ltd (290650) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.014x
Based on the latest financial reports, L&C Bio Co. Ltd (290650) has a cash flow conversion efficiency ratio of 0.014x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩3.79 Billion) by net assets (₩266.71 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
L&C Bio Co. Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how L&C Bio Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
L&C Bio Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of L&C Bio Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NCR Voyix Corporation
NYSE:VYX
|
0.012x |
|
Sanyang Motor Co Ltd
TW:2206
|
0.034x |
|
Kingsignal Technology Co Ltd
SHE:300252
|
-0.001x |
|
Shenzhen Coship Electronics Co Ltd
SHE:002052
|
0.245x |
|
Piedmont Office Realty Trust Inc
NYSE:PDM
|
0.040x |
|
Hapag-Lloyd Aktiengesellschaft
PINK:HLAGF
|
0.039x |
|
Charoen Pokphand Enterprise Taiwan Co Ltd
TW:1215
|
0.080x |
|
Qisda Corp
TW:2352
|
0.051x |
Annual Cash Flow Conversion Efficiency for L&C Bio Co. Ltd (2015–2024)
The table below shows the annual cash flow conversion efficiency of L&C Bio Co. Ltd from 2015 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩284.35 Billion | ₩-8.57 Billion | -0.030x | +63.51% |
| 2023-12-31 | ₩146.94 Billion | ₩-12.13 Billion | -0.083x | -33.11% |
| 2022-12-31 | ₩97.95 Billion | ₩-6.08 Billion | -0.062x | -148.35% |
| 2021-12-31 | ₩85.02 Billion | ₩10.91 Billion | 0.128x | -0.05% |
| 2020-12-31 | ₩57.81 Billion | ₩7.42 Billion | 0.128x | +16.12% |
| 2019-12-31 | ₩58.18 Billion | ₩6.43 Billion | 0.111x | +50.78% |
| 2018-12-31 | ₩52.46 Billion | ₩3.85 Billion | 0.073x | -67.72% |
| 2017-12-31 | ₩16.81 Billion | ₩3.82 Billion | 0.227x | +1327.62% |
| 2016-12-31 | ₩10.02 Billion | ₩-185.35 Million | -0.018x | +94.55% |
| 2015-12-31 | ₩3.91 Billion | ₩-1.33 Billion | -0.339x | -- |